Can GLP-1 Treatment Lower Blood Pressure? What to Know

Several large trials of GLP-1 and related medicines have reported lower average blood pressure alongside weight loss and other metabolic improvements. That's genuinely interesting, but it shouldn't be turned into a claim that these medicines replace blood-pressure treatment or that everyone's readings will fall. How big the effect is, and what it means, depends on the drug, the people studied, their other treatment and the study design.

What have trials reported?

• In STEP 1, adults with overweight or obesity (without diabetes) taking semaglutide 2.4 mg for 68 weeks had greater improvements in cardiometabolic risk factors, including blood pressure, than people on placebo.
• In a SURMOUNT-1 substudy, tirzepatide lowered 24-hour ambulatory blood pressure (measured by a wearable cuff throughout the day and night) compared with placebo in adults with a BMI of 27 or higher.
• In SURMOUNT-OSA, tirzepatide reduced systolic blood pressure compared with placebo in adults with obesity and sleep apnea.

These are average changes across groups in specific trials. As of October 2026, no GLP-1 medicine is approved in the US as a treatment for high blood pressure, and blood pressure isn't a listed indication on any of their labels.

Why blood pressure may change

Weight loss itself tends to lower blood pressure, and these medicines may also affect eating patterns, fluid balance and other metabolic processes. Researchers are still working out how much of the effect comes from weight loss and how much from other actions. Blood pressure is also shaped by salt intake, sleep, stress, pain, kidney function, alcohol, other medicines and how readings are taken.

There's an important flip side. If vomiting, diarrhea or eating and drinking much less leads to dehydration, blood pressure can drop too low and cause dizziness or fainting. That isn't a treatment benefit; it's a reason to call your care team. Our article on dizziness on GLP-1 covers this in more detail.

Track readings consistently

If your clinician has asked you to monitor blood pressure at home, use a validated, well-fitting cuff and the technique they recommend: sit quietly for a few minutes, back supported, feet flat and arm resting at heart level. Record readings at similar times of day. There's no need to measure over and over when you feel anxious. A single home reading isn't a diagnosis, and a change on the scale doesn't by itself mean blood-pressure medicines should be adjusted. For more ideas on tracking health measures beyond weight, see how to track GLP-1 progress beyond the scale.

When to speak up

Tell your care team if your readings are consistently higher or lower than your usual pattern, or if you feel lightheaded when standing. Call emergency services for fainting with injury, chest pain, severe shortness of breath, or stroke signs such as face drooping, arm weakness or trouble speaking. If you take blood-pressure medicines or water pills (diuretics), it's especially worth asking how to handle days when you can't eat or drink normally.

What the research does and doesn't support

Average changes in a trial help researchers estimate effects across a group. They don't promise that a GLP-1 medicine will control hypertension in any one person, and they don't create an approved indication. Check the current label and guidance in your country.

The useful approach is to treat blood pressure as one health measure to review with your clinician, not as a reason to self-adjust medicine because the scale has moved.